The C-terminal domain of PLD2 participates in degradation of protein kinase CKII β subunit in human colorectal carcinoma cells

BMB Reports

Volumn 44, Issue 9, 2011, Pages 572-577

  Lee, Young Hoon ^a   Uhm, Jong Su ^a   Yoon, Soo Hyun ^a   Kang, Ji Young ^a   Kim, Eun Kyung ^a   Kang, Beom Sik ^a   Min, Do Sik ^b   Bae, Young Seuk ^a  

^a Kyungpook National University   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

Colorectal carcinoma cells; Interaction domain; Phospholipase D2; Protein kinase CKII; Ubiquitin dependent degradation

Indexed keywords

CASEIN KINASE II; PHOSPHOLIPASE D; PHOSPHOLIPASE D2; SMALL INTERFERING RNA; UBIQUITIN;

ARTICLE; CELL STRAIN HCT116; COLORECTAL TUMOR; DRUG ANTAGONISM; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; PATHOLOGY; PROTEIN TERTIARY STRUCTURE; RNA INTERFERENCE;

CASEIN KINASE II; COLORECTAL NEOPLASMS; HCT116 CELLS; HUMANS; PHOSPHOLIPASE D; PROTEIN STRUCTURE, TERTIARY; RNA INTERFERENCE; RNA, SMALL INTERFERING; UBIQUITIN;

EID: 83655190827     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2011.44.9.572     Document Type: Article

References (17)

1. Exton, J. H. (1999) Regulation of phospholipase D. Biochim. Biophys. Acta 1439, 121-133.
2. Liscovitch, M., Czarny, M., Fiucci, G., and Tang, X. (2000) Phospholipase D: molecular and cell biology of a novel gene family. Biochem. J. 345, 401-415.
3. Rudge, S. A. and Wakelam, M. J. (2009) Inter-regulatory dynamics of phospholipase D and the actin cytoskeleton. Biochim. Biophys. Acta. 1791, 856-861.
4. Gomez-Cambronero, J. (2010) New concepts in phospholipase D signaling in inflammation and cancer. Scientific World J. 10, 1356-1369.
5. Su, W., Chen, Q., and Frohman, M. A. (2009) Targeting phospholipase D with small-molecule inhibitors as a potential therapeutic approach for cancer metastasis. Future Oncol. 5, 1477-1486.
6. Pinna, L. A. (1990) Casein kinase 2: an 'eminence grise' in cellular regulation? Biochim. Biophys. Acta. 1054, 267-284.
7. Issinger, O. G. (1993) Casein kinases: pleiotropic mediators of cellular regulation. Pharmacol. Ther. 59, 1-30.
8. Litchfield, D. W. (2003) Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem. J. 369, 1-15.
9. Krippner-Heidenreich, A., Talanian, R. V., Sekul, R., Kraft, R., Thole, H., Ottleben, H., and Luscher, B. (2001) Targeting of the transcription factor Max during apoptosis: phosphorylation-regulated cleavage by caspase-5 at an unusual glutamic acid residue in position P1. Biochem. J. 358, 705-715.
10. Desagher, S., Osen-Sand, A., Montessuit, S., Magnenat, E., Vilbois, F., Hochmann, A., Journot, L., Antonsson, B., and Martinou, J. C. (2001) Phosphorylation of bid by casein kinases I and II regulates its cleavage by caspase 8. Mol. Cell 8, 601-611.
11. Shin, S., Lee, Y., Kim, W., Ko, H., Choi, H., and Kim, K. (2005) Caspase-2 primes cancer cells for TRAIL-mediated apoptosis by processing procaspase-8. EMBO J. 24, 3532-3542.
12. Yoon, S. H, Min, D. S., and Bae, Y. S. (2009) Over-expression of phospholipase D isozymes down-regulates protein kinase CKII activity via proteasome-dependent CKIIβ degradation in NIH3T3 cells. Mol. Cells 27, 299-305.
13. Vorland, M., Thorsen, V. A., and Holmsen, H. (2008) Phospholipase D in platelets and other cells. Platelets 19, 582-594.
14. Zhang, C., Vilk, G., Canton, D. A., and Litchfield, D. W. (2002) Phosphorylation regulates the stability of the regulatory CK2β subunit. Oncogene 21, 3754-3764.
15. Min, D. S., Ahn, B. H., Rhie, D. J., Yoon, S. H., Hahn, S. J., Kim, M. S., and Jo, Y. H. (2001) Expression and regulation of phospholipase D during neuronal differentiation of PC12 cells. Neuropharmacol. 41, 384-391.
16. Kim, T. H., Lee, J. Y., Kang, B. S., and Bae, Y. S. (2005) In vitro characterization of protein kinase CKII β mutants defective in beta-beta dimerization. Mol. Cells 19, 124-130.
17. Fields, S. and Song, O. (1989) A novel genetic system to detect protein-protein interactions. Nature 340, 245-246.